Moors & Cabot’s Frontline FRO Stock Holding History

Moors & Cabot’s Portfolio FRO Stock Details FRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,000	Closed	-$189K	–	846
2023 Q2	$189K	Buy	13,000 +1,000	+8%	+$14.9K	0.01%	756
2023 Q1	$199K	Buy	+12,000	New	+$189K	0.01%	752

Other funds holding FRO

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Moors & Cabot's FRO Position: Q3 2023 in Review

Moors & Cabot sold out of Frontline (FRO) in Q3 2023, closing a stake of 13,000 shares — an estimated $189K sold.

Moors & Cabot first reported a position in FRO in Q1 2023 and held it in 2 quarters. The position peaked at $199K in Q1 2023. 167 funds tracked by Wall St. Rank hold FRO as of Q3 2023.

Moors & Cabot reported no remaining Frontline position as of Q3 2023 after selling out during the quarter.
Moors & Cabot sold 13,000 Frontline shares in Q3 2023, an estimated $189K.
Moors & Cabot first reported a position in Frontline in Q1 2023 and held it in 2 quarters.
Moors & Cabot's Frontline position peaked at $199K in Q1 2023.
167 funds tracked by Wall St. Rank held Frontline as of Q3 2023.

Based on Moors & Cabot's 13F filing for Q3 2023, filed 8 Nov 2023.